# Autologous Myoblast Intrasphincteric Injection for Fecal Incontinence

> **NCT01523522** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 24 (actual)

## Conditions studied

- Fecal Incontinence

## Interventions

- **OTHER:** Myoblast injection
- **PROCEDURE:** saline solution injection

## Key facts

- **NCT ID:** NCT01523522
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01523522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01523522, "Autologous Myoblast Intrasphincteric Injection for Fecal Incontinence". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01523522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*